NCT00019227View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1996

Study Completion Date

July 31, 2006

Conditions
LymphomaRadiation Toxicity
Interventions
DRUG

pentetic acid calcium

RADIATION

yttrium Y 90 daclizumab

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019227 - Monoclonal Antibody Therapy in Treating Patients With Leukemia | Biotech Hunter | Biotech Hunter